Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells

Accumulating evidence indicates that statins reduce the risk of different cancers and inhibit the proliferation of liver cancer cells. This study aims to explore whether the electrostatic conjugation of optimized fluvastatin (FLV) to human immunodeficiency virus type 1 (HIV-1) trans-activator transc...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Wahaibi, Lamya H., Al-Saleem, Muneera S. M., Ahmed, Osama A. A., Fahmy, Usama A., Alhakamy, Nabil A., Eid, Basma G., Abdel-Naim, Ashraf B., Abdel-Mageed, Wael M., AlRasheed, Maha M., Shazly, Gamal A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312570/
https://www.ncbi.nlm.nih.gov/pubmed/32531976
http://dx.doi.org/10.3390/ijms21114138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312570/
https://www.ncbi.nlm.nih.gov/pubmed/32531976
http://dx.doi.org/10.3390/ijms21114138

Ejemplares similares